Yang Gao

Yang Gao

Auto-generated profile, based on publicly available information

Yang Gao

Department of Neurosurgery Zhongshan Hospital, Fudan University Shanghai China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
YGYang Gao
Yang Gao
PWPeng‐Xiang Wang
Peng‐Xiang Wang
JCJian‐Wen Cheng
Jian‐Wen Cheng
YSYun‐Fan Sun
Yun‐Fan Sun
BHBo Hu
Bo Hu
XYXin-Rong Yang
Xin-Rong Yang
Background: Portal vein tumor thrombus (PVTT) is a common complication in hepatocellular carcinoma (HCC), signaling dismal outcomes. This study was conducted to evaluate the survival benefit of postoperative portal vein perfusion chemotherapy (PVC) in patients with HCC and PVTT.Methods: A retrospective review was conducted in 401 consecutive patients with HCC and PVTT who underwent hepatic resection between January 2009 and December 2015 and 67 patients received adjuvant postoperative PVC. A propensity score matching (PSM) was used to match patients with and without PVC at a ratio of 1:1.Results: After PSM, the median time to recurrence (TTR) and overall survival (OS) were significantly longer in PVC group compared with control group (12.3 vs 5.8 months, P = .001; 19.0 vs 13.4 months, P = .037; respectively). At 1, 2, 3, and 5 years, the cumulative recurrence rates in PVC group were 48.1%, 86.5%, 92.3% ,96.2%, respectively, with OS rates of 63.8%, 37.9%, 24.4%, 18.3%, respectively; whereas cumulative recurrence rates of 76.6%, 91.5%, 94.3%, and 97.2%, respectively and OS rates of 55.4%, 23.0%, 12.4%, and 12.4%, respectively were recorded for the control group. In multivariate analysis, postoperative PVC emerged as a significant predictor for TTR (hazard ratio [HR], 0.523; P = .001) and OS (HR, 0.591; P = .010). PVC could reduce early recurrence (≤1 year) rate after surgical resection (40.3% vs 64.2%, P = .006) and clinical outcomes were further enhanced by adding sorafenib to postoperative PVC.Conclusions: Compared with surgical resection alone, postoperative adjuvant PVC treatment boosts survival and reduces early tumor recurrences in patients surgically treated for HCC and PVTT.

5 August 2026 in Clinical Case Reports
Verified
Journal Article
Open access
YGYang Gao
Yang Gao
PZPuyuan Zhao
Puyuan Zhao
CLChen Li
Chen Li
QXQiang Xie
Qiang Xie
YXYijin Xiang
Yijin Xiang
ZYZhigang Yang
Zhigang Yang
This case presents that balloon passage via microwire navigation technology could be a beneficial option for patients with severe MCA stenosis, with the diameter of the proximal blood vessel in the stenotic segment is < 1.5 mm and there is antegrade blood flow.